Artelo Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $10,287,000.
Profit Margin
| 2014 | 0 | -15.26K | |
|---|---|---|---|
| 2015 | 0 | -15.24K | |
| 2016 | 0 | -29.69K | |
| 2017 | 0 | -234.88K | |
| 2018 | 0 | -2.34M | |
| 2019 | 0 | -2.17M | |
| 2020 | 0 | -4.65M | |
| 2021 | 0 | -7.43M | |
| 2022 | 0 | -9.87M |
ARTL Income Statement (2014 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||||||
Research and development | 4.32M | 2.83M | 1.91M | 1.09M | 1.24M | 0 | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 10.28M | 7.44M | 4.68M | 3.20M | 2.34M | 232.78K | 29.69K | 15.24K | 15.26K |
Operating income | -10.28M | -7.44M | -4.68M | -3.20M | -2.34M | -232.78K | -29.69K | -15.24K | -15.26K |
Other income (expenses), net | 204K | 2K | 30.91K | 1.03M | 0 | -2.1K | 0 | 0 | 0 |
Income before tax | -10.08M | -7.43M | -4.65M | -2.17M | -2.34M | -234.88K | -29.69K | -15.24K | -15.26K |
Income tax expense | -209K | -4K | -60.41K | -2.04M | 8 | 0 | 0 | 0 | 0 |
Net income | -9.87M | -7.43M | -4.65M | -2.17M | -2.34M | -234.88K | -29.69K | -15.24K | -15.26K |
Earnings per share | |||||||||
Basic EPS | -3.49 | -5.97 | -18.83 | -15 | -27.52 | -3.23 | -0.47 | -0.24 | -0.6 |
Diluted EPS | -3.49 | -5.97 | -18.83 | -15 | -27.52 | -3.23 | -0.47 | -0.24 | -0.6 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |